Dagrocorat
From WikiMD's WELLNESSPEDIA
Dagrocorat is a nonsteroidal but steroid-like selective glucocorticoid receptor modulator (SGRM) which was under development for the treatment of rheumatoid arthritis but was never marketed.
Developmental code name[edit]
The delopmental code names were: PF-00251802, PF-251802
Never marketed[edit]
The medication was never marketed by the pharmaceutical company for unknown reasons.
Mechanism of action[edit]
Dagrocorat is a novel and dissociated glucocorticoid receptor agonist.
Originator[edit]
Pfizer
Class of drug[edit]
Anti-inflammatories; Antirheumatics; Phenanthrenes; Pyridines; Small molecules
Orphan Drug Status[edit]
No
New Molecular Entity[edit]
Yes
Highest Development Phases[edit]
Phase 1
Current status[edit]
Discontinued
Proposed indication[edit]
Rheumatoid arthritis
Most Recent Events[edit]
- 27 Jan 2010Discontinued - Phase-I for Rheumatoid arthritis in USA (unspecified route)
- 03 Oct 2008Phase-I trials in Rheumatoid arthritis in USA (unspecified route)
Related molecules[edit]
Dagrocorat-2